Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010⁻2018.

Ianevski A, Zusinaite E, Shtaida N, Kallio-Kokko H, Valkonen M, Kantele A, Telling K, Lutsar I, Letjuka P, Metelitsa N, Oksenych V, Dumpis U, Vitkauskiene A, Stašaitis K, Öhrmalm C, Bondeson K, Bergqvist A, Cox RJ, Tenson T, Merits A, Kainov DE.

Viruses. 2019 Mar 1;11(3). pii: E207. doi: 10.3390/v11030207.

2.

Toxoplasma gondii seroprevalence in veterinarians in Finland: Older age, living in the countryside, tasting beef during cooking and not doing small animal practice associated with seropositivity.

Siponen AM, Kinnunen PM, Koort J, Kallio-Kokko H, Vapalahti O, Virtala AM, Jokelainen P.

Zoonoses Public Health. 2019 Mar;66(2):207-215. doi: 10.1111/zph.12550. Epub 2018 Dec 9.

PMID:
30536784
3.

No Association Between Ljungan Virus Seropositivity and the Beta-cell Damaging Process in the Finnish Type 1 Diabetes Prediction and Prevention Study Cohort.

Jääskeläinen AJ, Nurminen N, Kolehmainen P, Smura T, Tauriainen S, Toppari J, Ilonen J, Veijola R, Knip M, Hyöty H, Vapalahti O, Kallio-Kokko H.

Pediatr Infect Dis J. 2019 Mar;38(3):314-316. doi: 10.1097/INF.0000000000002201.

PMID:
30346370
4.

Validation of serological and molecular methods for diagnosis of zika virus infections.

Jääskeläinen AJ, Korhonen EM, Huhtamo E, Lappalainen M, Vapalahti O, Kallio-Kokko H.

J Virol Methods. 2019 Jan;263:68-74. doi: 10.1016/j.jviromet.2018.10.011. Epub 2018 Oct 18.

5.

Novel activities of safe-in-human broad-spectrum antiviral agents.

Ianevski A, Zusinaite E, Kuivanen S, Strand M, Lysvand H, Teppor M, Kakkola L, Paavilainen H, Laajala M, Kallio-Kokko H, Valkonen M, Kantele A, Telling K, Lutsar I, Letjuka P, Metelitsa N, Oksenych V, Bjørås M, Nordbø SA, Dumpis U, Vitkauskiene A, Öhrmalm C, Bondeson K, Bergqvist A, Aittokallio T, Cox RJ, Evander M, Hukkanen V, Marjomaki V, Julkunen I, Vapalahti O, Tenson T, Merits A, Kainov D.

Antiviral Res. 2018 Jun;154:174-182. doi: 10.1016/j.antiviral.2018.04.016. Epub 2018 Apr 23. Review.

PMID:
29698664
6.

Seroprevalence of lymphocytic choriomeningitis virus and Ljungan virus in Finnish patients with suspected neurological infections.

Fevola C, Kuivanen S, Smura T, Vaheri A, Kallio-Kokko H, Hauffe HC, Vapalahti O, Jääskeläinen AJ.

J Med Virol. 2018 Mar;90(3):429-435. doi: 10.1002/jmv.24966. Epub 2017 Nov 3.

PMID:
28976562
7.

Intertypic recombination of human parechovirus 4 isolated from infants with sepsis-like disease.

Kolehmainen P, Siponen A, Smura T, Kallio-Kokko H, Vapalahti O, Jääskeläinen A, Tauriainen S.

J Clin Virol. 2017 Mar;88:1-7. doi: 10.1016/j.jcv.2017.01.001. Epub 2017 Jan 3.

PMID:
28081453
8.

Lymphocytic choriomeningitis, Ljungan and orthopoxvirus seroconversions in patients hospitalized due to acute Puumala hantavirus infection.

Fevola C, Forbes KM, Mäkelä S, Putkuri N, Hauffe HC, Kallio-Kokko H, Mustonen J, Jääskeläinen AJ, Vaheri A.

J Clin Virol. 2016 Nov;84:48-52. doi: 10.1016/j.jcv.2016.10.002. Epub 2016 Oct 4.

PMID:
27721109
9.

Protein profiling of nasopharyngeal aspirates of hospitalized and outpatients revealed cytokines associated with severe influenza A(H1N1)pdm09 virus infections: A pilot study.

Fu Y, Gaelings L, Jalovaara P, Kakkola L, Kinnunen MT, Kallio-Kokko H, Valkonen M, Kantele A, Kainov DE.

Cytokine. 2016 Oct;86:10-14. doi: 10.1016/j.cyto.2016.07.003. Epub 2016 Jul 18.

PMID:
27442005
10.

Zika virus infection in a traveller returning from the Maldives, June 2015.

Korhonen EM, Huhtamo E, Smura T, Kallio-Kokko H, Raassina M, Vapalahti O.

Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30107.

11.

Serological survey in the Finnish human population implies human-to-human transmission of Ljungan virus or antigenically related viruses.

Jääskeläinen AJ, Voutilainen L, Lehmusto R, Henttonen H, Lappalainen M, Kallio-Kokko H, Vaheri A, Vapalahti O.

Epidemiol Infect. 2016 Apr;144(6):1278-85. doi: 10.1017/S0950268815002551. Epub 2015 Oct 22.

PMID:
26489898
12.

Comparative Analysis of Whole-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Hospitalized and Nonhospitalized Patients Identifies Missense Mutations That Might Be Associated with Patient Hospital Admissions in Finland during 2009 to 2014.

Mishel P, Ojala T, Benner C, Lakspere T, Bychkov D, Jalovaara P, Kakkola L, Kallio-Kokko H, Kantele A, Kankainen M, Ikonen N, Ripatti S, Julkunen I, Kainov DE.

Genome Announc. 2015 Jul 30;3(4). pii: e00676-15. doi: 10.1128/genomeA.00676-15.

13.

Development and evaluation of a real-time EBOV-L-RT-qPCR for detection of Zaire ebolavirus.

Jääskeläinen AJ, Moilanen K, Aaltonen K, Putkuri N, Sironen T, Kallio-Kokko H, Vapalahti O.

J Clin Virol. 2015 Jun;67:56-8. doi: 10.1016/j.jcv.2015.04.003. Epub 2015 Apr 7.

PMID:
25959160
14.

Complete Genome Sequences of Influenza A/H1N1 Strains Isolated from Patients during the 2013-2014 Epidemic Season in Finland.

Jalovaara P, Mishel P, Kallio-Kokko H, Valkonen M, Kantele A, Ikonen N, Julkunen I, Kakkola L, Kutsaya A, Vuorinen T, Mattila P, Almusa H, Kainov D.

Genome Announc. 2015 Mar 12;3(2). pii: e01523-14. doi: 10.1128/genomeA.01523-14.

15.

[Ebola: virus, disease, transmission--and preparedness in Finland].

Vapalahti O, Kallio-Kokko H, Anttila VJ, Lyytikäinen O.

Duodecim. 2014;130(21):2163-77. Finnish.

PMID:
25582011
16.

Influenza pH1N1 Virus Accumulated H275Y Mutation in Neuraminidase during Propagation in MDCK Cells.

Mishel P, Bychkov D, Kallio-Kokko H, Valkonen M, Kantele A, Mattila P, Almusa H, Jalovaara P, Kainov D.

Genome Announc. 2014 Dec 24;2(6). pii: e01349-14. doi: 10.1128/genomeA.01349-14.

17.

Development and evaluation of a real-time RT-qPCR for detection of Crimean-Congo hemorrhagic fever virus representing different genotypes.

Jääskeläinen AJ, Kallio-Kokko H, Ozkul A, Bodur H, Korukruoglu G, Mousavi M, Pranav P, Vaheri A, Mirazimi A, Vapalahti O.

Vector Borne Zoonotic Dis. 2014 Dec;14(12):870-2. doi: 10.1089/vbz.2014.1577.

18.

Human parechovirus type 3 and 4 associated with severe infections in young children.

Kolehmainen P, Jääskeläinen A, Blomqvist S, Kallio-Kokko H, Nuolivirta K, Helminen M, Roivainen M, Lappalainen M, Tauriainen S.

Pediatr Infect Dis J. 2014 Nov;33(11):1109-13. doi: 10.1097/INF.0000000000000401.

PMID:
25361406
19.

Genetic Instability of Influenza pH1N1 Viruses.

Jalovaara P, Bychkov D, Ahtiainen L, Kallio-Kokko H, Valkonen M, Kantele A, Mattila P, Almusa H, Kallioniemi O, Kainov D.

Genome Announc. 2014 Oct 2;2(5). pii: e00841-14. doi: 10.1128/genomeA.00841-14.

20.

Suspected YF-AND after yellow fever vaccination in Finland.

Jääskeläinen AJ, Huhtamo E, Kivioja R, Domingo C, Vene S, Kallio-Kokko H, Niedrig M, Tienari PJ, Vapalahti O.

J Clin Virol. 2014 Nov;61(3):444-7. doi: 10.1016/j.jcv.2014.08.022. Epub 2014 Sep 3.

PMID:
25223921
21.

Full-Genome Sequences of Influenza H3N2 Virus Strains Isolated from Finnish Patients during the 2012-2013 Epidemic Season.

Lakspere T, Kallio-Kokko H, Kantele A, Mattila P, Almusa H, Kainov D, Kakkola L.

Genome Announc. 2014 Mar 27;2(2). pii: e00039-14. doi: 10.1128/genomeA.00039-14.

22.

Performance of a multiplexed serological microarray for the detection of antibodies against central nervous system pathogens.

Jääskeläinen AJ, Viitala SM, Kurkela S, Hepojoki S, Sillanpää H, Kallio-Kokko H, Bergström T, Suni J, Närvänen A, Vapalahti O, Vaheri A.

J Microbiol Methods. 2014 May;100:27-31. doi: 10.1016/j.mimet.2014.02.011. Epub 2014 Mar 1.

PMID:
24594410
23.

Full-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Finnish Patients from 2009 to 2013.

Lakspere T, Tynell J, Kaloinen M, Vanlede M, Parsons A, Ikonen N, Kallio-Kokko H, Kantele A, Mattila P, Almusa H, Julkunen I, Kainov D, Kakkola L.

Genome Announc. 2014 Jan 16;2(1). pii: e01004-13. doi: 10.1128/genomeA.01004-13.

24.

First two cases of neonatal human parechovirus 4 infection with manifestation of suspected sepsis, Finland.

Jääskeläinen AJ, Kolehmainen P, Kallio-Kokko H, Nieminen T, Koskiniemi M, Tauriainen S, Lappalainen M.

J Clin Virol. 2013 Sep;58(1):328-30. doi: 10.1016/j.jcv.2013.06.010. Epub 2013 Jul 15.

PMID:
23867007
25.

Evidence of Ljungan virus specific antibodies in humans and rodents, Finland.

Jääskeläinen AJ, Kolehmainen P, Voutilainen L, Hauffe HC, Kallio-Kokko H, Lappalainen M, Tolf C, Lindberg AM, Henttonen H, Vaheri A, Tauriainen S, Vapalahti O.

J Med Virol. 2013 Nov;85(11):2001-8. doi: 10.1002/jmv.23681. Epub 2013 Jul 12.

PMID:
23852812
26.

Molecular evolution and epidemiology of echovirus 6 in Finland.

Smura T, Kakkola L, Blomqvist S, Klemola P, Parsons A, Kallio-Kokko H, Savolainen-Kopra C, Kainov DE, Roivainen M.

Infect Genet Evol. 2013 Jun;16:234-47. doi: 10.1016/j.meegid.2013.02.011. Epub 2013 Feb 24.

PMID:
23462388
27.

Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection.

Denisova OV, Kakkola L, Feng L, Stenman J, Nagaraj A, Lampe J, Yadav B, Aittokallio T, Kaukinen P, Ahola T, Kuivanen S, Vapalahti O, Kantele A, Tynell J, Julkunen I, Kallio-Kokko H, Paavilainen H, Hukkanen V, Elliott RM, De Brabander JK, Saelens X, Kainov DE.

J Biol Chem. 2012 Oct 12;287(42):35324-32. doi: 10.1074/jbc.M112.392142. Epub 2012 Aug 21.

28.

Validation and diagnostic application of NS and HA gene-specific real-time reverse transcription-PCR assays for detection of 2009 pandemic influenza A (H1N1) viruses in clinical specimens.

Rönkkö E, Ikonen N, Kontio M, Haanpää M, Kallio-Kokko H, Mannonen L, Lappalainen M, Julkunen I, Ziegler T.

J Clin Microbiol. 2011 May;49(5):2009-11. doi: 10.1128/JCM.00259-11. Epub 2011 Mar 2.

29.

Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland.

Ikonen N, Haanpää M, Rönkkö E, Lyytikäinen O, Kuusi M, Ruutu P, Kallio-Kokko H, Mannonen L, Lappalainen M, Ziegler T, Julkunen I.

PLoS One. 2010 Oct 20;5(10):e13329. doi: 10.1371/journal.pone.0013329.

30.

Imported human rabies, the Philippines and Finland, 2007.

Rimhanen-Finne R, Järvinen A, Kuusi M, Quiambao BP, Malbas FF Jr, Huovilainen A, Kallio-Kokko H, Vapalahti O, Ruutu P.

Emerg Infect Dis. 2010 Aug;16(8):1318-9. doi: 10.3201/eid1608.091380. No abstract available.

31.

[Rabies].

Mattila L, Kolho E, Vapalahti O, Huovilainen A, Kanerva M, Järvinen A, Siikamäki H, Kallio-Kokko H, Lauhio A.

Duodecim. 2010;126(4):418-25. Finnish.

PMID:
20486492
32.

Serological survey for viral pathogens in Turkish rodents.

Laakkonen J, Kallio-Kokko H, Oktem MA, Blasdell K, Plyusnina A, Niemimaa J, Karataş A, Plyusnin A, Vaheri A, Henttonen H.

J Wildl Dis. 2006 Jul;42(3):672-6.

PMID:
17092901
33.

Is there an association of Pneumocystis infection with the presence of arena-, hanta-, and poxvirus antibodies in wild mice and shrews in Finland?

Laakkonen J, Kallio ER, Kallio-Kokko H, Vapalahti O, Vaheri A, Henttonen H.

Parasitology. 2006 Apr;132(Pt 4):461-6.

PMID:
16556344
34.

Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection.

Seitsonen E, Hynninen M, Kolho E, Kallio-Kokko H, Pettilä V.

Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):261-6.

PMID:
16550348
35.

Hantavirus and arenavirus antibody prevalence in rodents and humans in Trentino, Northern Italy.

Kallio-Kokko H, Laakkonen J, Rizzoli A, Tagliapietra V, Cattadori I, Perkins SE, Hudson PJ, Cristofolini A, Versini W, Vapalahti O, Vaheri A, Henttonen H.

Epidemiol Infect. 2006 Aug;134(4):830-6. Epub 2005 Dec 22.

36.

Viral zoonoses in Europe.

Kallio-Kokko H, Uzcategui N, Vapalahti O, Vaheri A.

FEMS Microbiol Rev. 2005 Nov;29(5):1051-77. Epub 2005 Jun 29. Review.

37.

Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells.

Kallio-Kokko H, Leveelahti R, Brummer-Korvenkontio M, Lundkvist A, Vaheri A, Vapalahti O.

J Med Virol. 2001 Nov;65(3):605-13.

PMID:
11596100
38.

Antigenic properties and diagnostic potential of recombinant dobrava virus nucleocapsid protein.

Kallio-Kokko H, Lundkvist A, Plyusnin A, Avsic-Zupanc T, Vaheri A, Vapalahti O.

J Med Virol. 2000 Jun;61(2):266-74.

PMID:
10797384
39.
40.

Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.

Salonen EM, Parren PW, Graus YF, Lundkvist A, Fisicaro P, Vapalahti O, Kallio-Kokko H, Vaheri A, Burton DR.

J Gen Virol. 1998 Apr;79 ( Pt 4):659-65.

PMID:
9568958
41.

Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica).

Sjölander KB, Elgh F, Kallio-Kokko H, Vapalahti O, Hägglund M, Palmcrantz V, Juto P, Vaheri A, Niklasson B, Lundkvist A.

J Clin Microbiol. 1997 Dec;35(12):3264-8.

42.

Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity.

Lundkvist A, Kallio-Kokko H, Sjölander KB, Lankinen H, Niklasson B, Vaheri A, Vapalahti O.

Virology. 1996 Feb 15;216(2):397-406.

43.

Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

Vapalahti O, Lundkvist A, Kallio-Kokko H, Paukku K, Julkunen I, Lankinen H, Vaheri A.

J Clin Microbiol. 1996 Jan;34(1):119-25.

44.

Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response.

Vapalahti O, Kallio-Kokko H, Närvänen A, Julkunen I, Lundkvist A, Plyusnin A, Lehväslaiho H, Brummer-Korvenkontio M, Vaheri A, Lankinen H.

J Med Virol. 1995 Aug;46(4):293-303.

PMID:
7595404
45.

Tula virus: a newly detected hantavirus carried by European common voles.

Plyusnin A, Vapalahti O, Lankinen H, Lehväslaiho H, Apekina N, Myasnikov Y, Kallio-Kokko H, Henttonen H, Lundkvist A, Brummer-Korvenkontio M, et al.

J Virol. 1994 Dec;68(12):7833-9.

46.

Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen.

Kallio-Kokko H, Vapalahti O, Hedman K, Brummer-Korvenkontio M, Vaheri A.

J Clin Microbiol. 1993 Mar;31(3):677-80.

47.

Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein.

Vapalahti O, Kallio-Kokko H, Salonen EM, Brummer-Korvenkontio M, Vaheri A.

J Gen Virol. 1992 Apr;73 ( Pt 4):829-38.

PMID:
1353107

Supplemental Content

Loading ...
Support Center